Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140).
Shearer
William T
WT
DeVille
Jaime G
JG
Samson
Pearl M
PM
Moye
John H
JH
Fletcher
Courtney V
CV
Church
Joseph A
JA
Spiegel
Hans M L
HM
Palumbo
Paul
P
Fenton
Terence
T
Smith
M Elizabeth
ME
Graham
Bobbie
B
Kraimer
Joyce M
JM
Olson
William C
WC
D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D061067:Antibodies, Monoclonal, Humanized; D016860:CD4 Immunoadhesins / Q000494:pharmacology*; D002648:Child; D002675:Child, Preschool; D015483:HIV Antibodies / Q000494:pharmacology*; D015497:HIV-1 / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D066298:In Vitro Techniques; D019713:Receptors, CCR5 / Q000276:immunology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D016860:CD4 Immunoadhesins; C096753:CD4-IgG(2); D015483:HIV Antibodies; D019713:Receptors, CCR5; C420063:leronlimab